High-performance liquid chromatographic method for the determination of pioglitazone in human plasma using ultraviolet detection and its application to a pharmacokinetic study

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 843, Issue 2, 2006, Pages 164-169

  Sripalakit, Pattana ^a   Neamhom, Penporn ^a   Saraphanchotiwitthaya, Aurasorn ^a  

^a NARESUAN UNIVERSITY   (Thailand)

Author keywords

HPLC; Pharmacokinetics; Pioglitazone; Quantification; Reversed phase chromatography; Solid phase extraction; Validation

Indexed keywords

ACETONITRILE; BIOASSAY; CALIBRATION; PHARMACOKINETICS; SENSITIVITY ANALYSIS; SEPARATION; ULTRAVIOLET RADIATION;

PIOGLITAZONE; QUANTIFICATION; REVERSED-PHASE CHROMATOGRAPHY; SOLID PHASE EXTRACTION;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ACETONITRILE; BUFFER; GLUBOSIL; METHANOL; PHOSPHATE; PIOGLITAZONE; ROSIGLITAZONE;

ACCURACY; ADULT; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THIAZOLIDINEDIONES; ULTRAVIOLET RAYS;

EID: 33750295486     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.05.032     Document Type: Article

References (13)

1. Waugh J., Keating G.M., Plosker G.L., Easthope S., and Robinson D.M. Drugs 66 (2006) 85
2. Chilcott J., Tappenden P., Lloyd M., and Wight J.P. Clin. Ther. 23 (2001) 1792
3. ® (pioglitazone hydrochloride) Full Prescribing Information, Osaka, Japan, 2004, http://www.actos.com/pi.pdf.
4. Zhong W.Z., and Lakings D.B. J. Chromatogr. B Biomed. Sci. Appl. 490 (1989) 377
5. Zhong W.Z., and Williams M.G. J. Pharm. Biomed. Anal. 14 (1996) 465
6. Yamashita K., Murakami H., Okuda T., and Motohashi M. J. Chromatogr. B 677 (1996) 141
7. Lin Z.J., Ji W., Desai-Krieger D., and Shum L. J. Pharm. Biomed. Anal. 33 (2003) 101
8. Xue Y.H., Turner K.C., Meeker J.B., Pursley J., Arnold M., and Unger S. J. Chromatogr. B 795 (2003) 215
9. US Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation, Center for Drug Evaluation and Research, Rockville, MD, 2001, http://www.fda.gov/cder/guidance/4252fnl.pdf.
10. Eckland D.A., and Danhof M. Exp. Clin. Endocrinol. Diabetes 108 Suppl. 2 (2000) 234
11. Hanefeld M. Int. J. Clin. Pract. Suppl. 121 (2001) 19
12. Christensen M.L., Meibohm B., Capparelli E.V., Velasquez-Mieyer P., Burghen G.A., and Tamborlane W.V. J. Clin. Pharmacol. 45 (2005) 1137
13. Wong H., Ozalp Y., Lainesse A., and Alpan R.S. Arzneimittelforschung 54 (2004) 618